Bio-Path Holdings, Inc.
BPTH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $159 | $178 | $178 | $161 |
| Gross Profit | -$159 | -$178 | -$178 | -$161 |
| % Margin | – | – | – | – |
| R&D Expenses | $7,295 | $11,608 | $9,165 | $5,910 |
| G&A Expenses | $4,697 | $4,112 | $4,736 | $4,533 |
| SG&A Expenses | $4,697 | $4,235 | $4,736 | $4,533 |
| Sales & Mktg Exp. | $0 | $123 | $0 | $0 |
| Other Operating Expenses | -$159 | $0 | $0 | $0 |
| Operating Expenses | $11,833 | $15,843 | $13,901 | $10,443 |
| Operating Income | -$11,992 | -$15,843 | -$13,901 | -$10,443 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2,098 | -$235 | $33 | $3 |
| Pre-Tax Income | -$9,894 | -$16,078 | -$13,868 | -$10,440 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9,894 | -$16,078 | -$13,835 | -$10,437 |
| % Margin | – | – | – | – |
| EPS | -4.12 | -33.64 | -38.03 | -31.04 |
| % Growth | 87.8% | 11.5% | -22.5% | – |
| EPS Diluted | -4.12 | -33.64 | -38.03 | -31.04 |
| Weighted Avg Shares Out | 2,401 | 478 | 364 | 336 |
| Weighted Avg Shares Out Dil | 2,401 | 478 | 364 | 336 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14 | $36 | $33 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $159 | $82 | $178 | $161 |
| EBITDA | -$9,735 | -$15,761 | -$13,690 | -$10,279 |
| % Margin | – | – | – | – |